Patents by Inventor Anat Cohen-Dayag

Anat Cohen-Dayag has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • POLYPEPTIDES AND POLYNUCLEOTIDES, AND USES THEREOF AS A DRUG TARGET FOR PRODUCING DRUGS AND BIOLOGICS
    Publication number: 20110311450
    Abstract: This invention relates to a novel target for production of immune and non-immune based therapeutics and for disease diagnosis. More particularly, the invention provides therapeutic antibodies against KRTCAP3, FAM26F, MGC52498, FAM70A or TMEM154 antigens, which are differentially expressed in cancer, and diagnostic and therapeutic usages. This invention further relates to extracellular domains of KRTCAP3, FAM26F, MGC52498, FAM70A and TMEM154 proteins and variants, and therapeutic usages thereof.
    Type: Application
    Filed: December 8, 2009
    Publication date: December 22, 2011
    Inventors: Zurit Levine, Avi Rosenberg, Galit Rotman, Amit Novik, Amir Toporik, Yaron Kinar, Sergey Nemzer, Shira Walach, Eve Montia, Shirley Sameach-Greenwald, Liat Dassa, Merav Beiman, Anat Cohen-Dayag, Ofer Levy
  • POLYPEPTIDES AND POLYNUCLEOTIDES, AND USES THEREOF AS A DRUG TARGET FOR PRODUCING DRUGS AND BIOLOGICS
    Publication number: 20110052501
    Abstract: This invention relates to a novel target for production of immune and non-immune based therapeutics and for disease diagnosis. More particularly, the invention provides therapeutic antibodies against KIAA0746, CD20 or CD55 antigens, which are differentially expressed in cancer and in specific blood cells, and diagnostic and therapeutic usages. This invention further relates to the discovery of extracellular domains of KIAA0746 and its variants, CD20 and its variants, CD55 and its variants, which are suitable targets for immunotherapy, cancer therapy, treatment of inflammatory, allergic and autoimmune disorders, and drug development.
    Type: Application
    Filed: February 1, 2009
    Publication date: March 3, 2011
    Inventors: Liat Dassa, Galit Rotman, Eve Montia, Avi Yeshah Rosenberg, Anat Cohen-Dayag, Amir Toporik, Zurit Levine, Shira Walach, Shirley Sameach-Greenwald, Yaron Kinar, Ofer Levy, Sergey Nemzar
  • BIOMARKERS FOR THE PREDICTION OF RENAL INJURY
    Publication number: 20110003708
    Abstract: The present invention relates to means and methods for predicting the onset of renal injury based on measuring the expression of polynucleotides and proteins, particularly on measuring the expression of sets of novel as well as known polynucleotides and proteins, and to kits utilizing same.
    Type: Application
    Filed: June 25, 2010
    Publication date: January 6, 2011
    Applicant: COMPUGEN LTD.
    Inventors: Yaron Kinar, Merav Beiman, Eve Montia, Shira Walach, Tania Pergam, Amit Novik, Shirley Sameah-Greenwald, Gad S. Cojocaru, Anat Cohen-Dayag, Yael Furman
  • NOVEL DIAGNOSTIC MARKERS, ESPECIALLY FOR IN VIVO IMAGING, AND ASSAYS AND METHODS OF USE THEREOF
    Publication number: 20100189652
    Abstract: Novel splice variants as diagnostic markers, preferably membrane-bound. The novel variants according to the present invention may optionally be used for diagnosis of Marker-detectable disease as described herein, optionally through immunohistochemistry.
    Type: Application
    Filed: April 12, 2010
    Publication date: July 29, 2010
    Inventors: SARAH POLLOCK, ANAT COHEN-DAYAG, OSNAT SELLA-TAVOR, SHIRLEY SAMEAH-GREENWALD, SHIRA WALACH, LILY BAZAK
  • Diagnostic markers, especially for in vivo imaging and assays and methods of use thereof
    Patent number: 7741433
    Abstract: Novel splice variants as diagnostic markers, preferably membrane-bound. The novel variants according to the present invention may optionally be used for diagnosis of Marker-detectable disease as described herein, optionally through immunohistochemistry.
    Type: Grant
    Filed: October 30, 2007
    Date of Patent: June 22, 2010
    Assignee: Compugen Ltd.
    Inventors: Sarah Pollock, Anat Cohen-Dayag, Osnat Sella-Tavor, Shirley Sameah-Greenwald, Shira Walach, Lily Bazak
  • NOVEL DIAGNOSTIC MARKERS, ESPECIALLY FOR IN VIVO IMAGING AND ASSAYS AND METHODS OF USE THEREOF
    Publication number: 20090202991
    Abstract: Novel splice variants as diagnostic markers, preferably membrane-bound. The novel variants according to the present invention may optionally be used for diagnosis of Marker-detectable disease as described herein, optionally through immunohistochemistry.
    Type: Application
    Filed: October 30, 2007
    Publication date: August 13, 2009
    Inventors: Sarah POLLOCK, Anat Cohen-Dayag, Osnat Sella-Tavor, Shirley Sameah-Greenwald, Shira Walach, Lily Bazak
  • Diagnostic markers, especially for in vivo imaging, and assays and methods of use thereof
    Patent number: 7488813
    Abstract: Novel splice variants as diagnostic markers, preferably membrane-bound. The novel variants according to the present invention may optionally be used for diagnosis of Marker-detectable disease as described herein, optionally through immunohistochemistry.
    Type: Grant
    Filed: February 24, 2006
    Date of Patent: February 10, 2009
    Assignee: Compugen, Ltd.
    Inventors: Sarah Pollock, Anat Cohen-Dayag, Osnat Sella-Tavor, Shirley Sameah-Greenwald, Shira Walach, Lily Bazak
  • Novel diagnostic markers, especially for in vivo imaging, and assays and methods of use thereof
    Publication number: 20060257896
    Abstract: Novel splice variants as diagnostic markers, preferably membrane-bound. The novel variants according to the present invention may optionally be used for diagnosis of Marker-detectable disease as described herein, optionally through immunohistochemistry.
    Type: Application
    Filed: February 24, 2006
    Publication date: November 16, 2006
    Applicant: Compugen Ltd.
    Inventors: Sarah Pollock, Anat Cohen-Dayag, Osnat Sella-Tavor, Shirley Sameah-Greenwald, Shira Walach, Lily Bazak